Testing effectiveness (Phase 2)Study completedNCT03389295
What this trial is testing
Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Who this might be right for
Nasopharyngeal Carcinoma
Xiayun He, MD 118